Kenvue Inc. (KVUE) Average EV/EBIT Ratio
The current ev/ebit ratio for Kenvue Inc. (KVUE) is 14.32x as of Wednesday, June 24, 2026, shown against its trailing averages.
KVUE Average EV/EBIT Ratio Chart
KVUE EV/EBIT Ratio Averages
EV/EBIT RATIO CURRENT
14.32x
EV/EBIT RATIO TTM
17.76x
EV/EBIT RATIO 3Y
20.64x
EV/EBIT RATIO 5Y
20.50x
EV/EBIT RATIO 10Y
20.50x
EV/EBIT RATIO 15Y
20.50x
EV/EBIT RATIO 20Y
20.50x
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Kirk L. Perry